Event Details
World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
Dec 4 - Dec 6, 2025
Title: Baseline Characteristics and Rationale of the SHASTA-3 and SHASTA-4 Phase 3 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
Presenter: Norman Lepore
Title: Recurrent Hospital Admissions in Acute Pancreatitis and Persistent Chylomicronemia
Presenter: Rohit Loomba
Title: A Monte Carlo Simulation Comparing TG Lowering with Plozasiran versus Olezarsan in Patients with FCS
Presenter: Nihar Desai
Title: Plozasiran Decreases the Risk of AP and may Improve QOL in FCS
Encore Presentation
Title: A Randomized Placebo Controlled Phase 3 Study of Plozasiran in Patients with FCS: Palisade 1-Year OLE
Encore Presentation